Meridian Medical Technologies Expanding Missouri Facility

Meridian Medical Technologies, a Kindeva Drug Delivery Company, is expanding its manufacturing capabilities in Bridgeton, Mo., investing more than $100 million over the next four years in a newly purchased facility. Meridian, which combined with Kindeva late last year, is converting this new 155,000-square-foot facility to increase production of drug-device combination products, sterile fill-finish capabilities, and create job opportunities in the St. Louis area.
 
“We’re proud to have a high-tech manufacturer like Meridian Medical Technologies expanding in St. Louis,” Missouri Gov. Mike Parson said. “It’s always exciting to see a local employer thriving, creating jobs, and developing innovative products right here in our state. We wish Meridian the best and look forward to its future growth as it continues to succeed in the region.”
 
Meridian founded the autoinjector technology and has been a leading manufacturer of emergency autoinjectors for more than 60 years. Now with Kindeva, the combined company has a broader range of drug delivery capabilities that this Bridgeton facility investment will help support worldwide.
 
“Meridian brings a strong history of specific expertise to support critical manufacturing capabilities for complex products—addressing a manufacturing shortage we have seen increase over the last several years,” Meridian Medical Technologies CEO Milton Boyer stated. “Building a broader platform with the latest technologies and equipment available, coupled with enhanced capabilities in the production of pre-filled syringes and cartridges, will enable Meridian to offer a broader array of CDMO services and increased capacity to our customers.”
 
Since January 2022, Meridian has added approximately 300 employees for a total of approximately 900 in the St. Louis area. The company’s new facility, completed next year, will support continued growth by dramatically increasing its abilities to develop and manufacture products that will bring new medicines to new markets and customers worldwide.
 
For this expansion, Meridian will benefit from the Missouri Works program, a tool that helps companies expand and retain workers by providing access to capital through withholdings or tax credits for job creation.
 
“It’s exciting to see Meridian Medical Technologies create more opportunities for Missourians in St. Louis,” said Maggie Kost, acting director of the Department of Economic Development. “As Meridian expands while developing lifesaving products, we’re grateful to support its growth. This company is another example of a quality local employer making a positive difference for our state and beyond.”
 
“The city of Bridgeton welcomes Meridian Medical Technologies to the city,” Mayor Terry Briggs said. “Not only will Meridian bring well-paying jobs to our city, but the medical products it develops here will help countless people throughout the world. We look forward to working with them.”
 
“Meridian’s expansion brings not only new investment and new jobs to the St. Louis metro, but highlights the continued growth of our bioscience and advanced manufacturing sectors,” said Jason Hall, CEO of Greater St. Louis Inc. “We are excited by Meridian’s expansion and their commitment to St. Louis and appreciate the hard work and collaboration of the economic development partners at the state and regional level who helped make this project happen.”
 
“The St. Louis region has so much to offer in the biosciences and medical industry. We are excited Meridian Medical Technologies will be expanding its operations here and bringing more jobs to Missouri,” said Tara Oglesby, vice president of Community, Economic Development and Energy Solutions at Ameren Missouri. “Ameren Missouri’s Smart Energy Plan continues to be instrumental in making the region more attractive for businesses to grow here while also providing reliable energy to power the quality of life for the customers and communities we serve.”
 
Kindeva is a global contract development manufacturing organization focused on drug-device combination products. Kindeva develops and manufactures products across a range of complex drug-delivery formats, including autoinjectors, inhalers, transdermal patches, and microneedles. Its service offering spans early-stage feasibility through commercial scale drug product fill-finish, container closure system manufacturing, and drug-device product assembly. Kindeva serves a global client base from its nine manufacturing and research and development facilities located in the United States and United Kingdom.